New Hepatitis C Drug Curing Between 80 and 90 Percent of Patients

Officials in the United States have approved a new hepatitis drug, and it has been hastily embraced by doctors based on its once-a-day regimen and increased effectiveness for curing between 80 and 90 percent of patients.

An estimated 3.2 million persons in the United States have chronic Hepatitis C virus infection. It is typically usually spread when blood from a person infected with the Hepatitis C virus enters the body of someone who is not infected.

Learn More... New Hepatitis C Drug Curing Between 80 and 90 Percent of Patients